Biotech · Private company
RedDress Ltd.
Track this companyFree. Adds RedDress Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- RedDress Wound Care System (RD1)Phase 2 · Neuropathic Diabetic Ulcer - FootClinicalTrials.gov · fetched Nov 12, 2026
- ActiGraftCutaneous WoundsClinicalTrials.gov · fetched Nov 12, 2026
- ActiGraftDiabetic FootClinicalTrials.gov · fetched Nov 12, 2026
- RD1 SystemDiabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- RD2 Ver.02Anal FistulaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal FistulasNA · RECRUITING · started Jan 20, 2024ClinicalTrials.gov NCT05641844 · fetched Nov 12, 2026
- Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUsNA · COMPLETED · started Dec 20, 2019ClinicalTrials.gov NCT04185558 · fetched Nov 12, 2026
- Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical CentersRECRUITING · started Feb 14, 2019ClinicalTrials.gov NCT04699305 · fetched Nov 12, 2026
- A Prospective, Open Label, Multicenter Trial for Evaluating the Efficacy of Treating and Managing Wounds in Elderly Population in Specialized Nursing Facilities Using RD1NA · TERMINATED · started Jul 11, 2018ClinicalTrials.gov NCT04577183 · fetched Nov 12, 2026
- Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.PHASE2 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT01396837 · fetched Nov 12, 2026